학술논문
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial
Document Type
Article
Author
Bian, H.; Zheng, Z.-H.; Sun, X.-X.; Geng, J.-J.; Chen, R.; Wang, K.; Yang, X.; Chen, S.-R.; Chen, S.-Y.; Xie, R.-H.; Zhang, K.; Miao, J.-L.; Jia, J.-F.; Wei, D.; Zhang, Z.; Chen, Z.-N.; Zhu, P.; Chen, L.; Tang, H.; Liu, S.-S.; Shi, H.-W.; Yang, Y.; Chen, X.-C.; Malhotra, V.; Nasir, N.; Khanum, I.; Mahmood, F.; Hamid, S.; Stadnik, C.M.B.; Itinose, K.; de Oliveira, C.C.C.; Dusilek, C.; Rivabem, L.; Cavalcante, A.J.W.; Lopes, S.S.; Saporito, W.F.; Fucci, F.J.C.; Simon-Campos, J.A.; Wang, L.; Liu, L.-N.; Wang, Q.-Y.
Source
In: Signal Transduction and Targeted Therapy . (Signal Transduction and Targeted Therapy, December 2023, 8(1))
Subject
Language
English
ISSN
20593635
20959907
20959907